In-Depth Analysis of the Cancer Profiling Market: Trends and Forecasts for 2024-30

Global Quick Overview of the Cancer Profiling Market Analysis

The objective of the Global Cancer Profiling Market Research Report is to provide a detailed and useful data, and a geographical perspective for predictions of future. The recommendations included in the report are supposed to be insightful and actionable, offering a thorough understanding of the industry. Moreover, it includes a comprehensive table of contents, relevant data, and an analysis of numerous important aspects that have impacted the market.

According to the latest report analysis by MarkNtel Advisors, the Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30. This detailed study provides a detailed overview of the current market state, including market trends, opportunities, along with the recent developments. In-depth analysis of market share, size, forecast, and competitive landscape is also covered in this report that presents a clear picture of the industry with relevant statistical data.

In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.

Latest Challenge Contributing in the Cancer Profiling Industry:

Global Cancer Profiling Market Challenge:

High Capital Investment in Biomarker Discovery to Hinder the Market Growth – Biomarkers are an integral part of cancer profiling services, as the development of new cancer biomarkers for different cancer indications paves the way for profiling. Pharmaceutical companies like Theseus Pharmaceuticals, Inc., ‎Nektar Therapeutics, Exact Sciences Corporation, etc., have been facing issues like severe side effects, which have led to the termination of their clinical trial studies for biomarkers.

Hence, the high capital investment and associated chances for clinical trial termination have been affecting the adequate development of new biomarkers. Therefore, this has been affecting the reliability of cancer profiling services for new application areas, which has been negatively affecting the market growth.

A Detailed Outlook of Cancer Profiling Market Segmentation

The Market Segmentation analysis provides and accurate data of the industry to help the analysts make smart strategic investment decisions. Also, the prediction of the market is included for national, and level in the research. The study analyses latest trends of the industry from 2024-30 for each of the category. Different segments were used to classify the market for this study are listed below:

-By Type of Cancer

Breast Cancer - Market Size & Forecast 2019-2030, USD Million
Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million
Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million
‎Leukemia - Market Size & Forecast 2019-2030, USD Million
Prostate Cancer - Market Size & Forecast 2019-2030, USD Million
Lung Cancer - Market Size & Forecast 2019-2030, USD Million
Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Technology

Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million
Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million
Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million
In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million
Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million
Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Biomarker Type

Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Cell Type

Germline - Market Size & Forecast 2019-2030, USD Million
Somatic - Market Size & Forecast 2019-2030, USD Million

-By Application

Oncology Research - Market Size & Forecast 2019-2030, USD Million
Precision Medicine - Market Size & Forecast 2019-2030, USD Million
Clinical Diagnostics - Market Size & Forecast 2019-2030, USD Million
Others (Prognosis, Monitoring and Recurrence Detection, etc.) - Market Size & Forecast 2019-2030, USD Million

-By End-User

Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million
Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million
Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million
Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million

Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/cancer-profiling-market.html

Geographical Analysis:

-By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

Among them, North America has been dominating the Global Cancer Profiling Market over the historical years. This has been mainly attributed to the unhealthy lifestyle of consumers, which has been leading to the rising prevalence of cancer across the region. For instance, in 2020, the American Cancer Society reported that there were around 1.8 million new cancer cases diagnosed in the United States alone. Hence, the need for cancer panels and profiling has improved with a growing cancer burden, which has contributed to the overall growth of the market across the region.

Further, the American Cancer Society has also predicted that the cancer rate is projected to increase across the US in the coming years, which would contribute to the region’s dominance in the market in the coming years as well.

Lead the Cancer Profiling Market with a Deep Evaluation of the Competition

This report also includes accurate facts, figures, and market data into income assessments, and projections in the industry by using a wide range of statistical tools and knowledge about the market by the experts. Each notable market participant has a SWOT evaluation, a profile and a complementary Porter’s Five Forces analysis.

Moreover, to take the benefits of new opportunities, dominating players have been constantly realigning their systems, and methods of operation. We also evaluate major businesses that are influences on a geographical scale along with the small and medium-sized businesses that plays crucial role and have substantial opportunity for expansion in order to accurately reflect the levels of market competition.

The details on the following key players is presented in this section as:

NeoGenomics Laboratories
Eurofins Genomics GmbH
Hoffmann-La Roche Ltd (Foundation Medicine)
OncoDNA SA
10x Genomics, Inc.
Caris Life Sciences.
Geneseeq Technology Inc.
Genetron Holdings Limited
Laboratory Corporation of America Holdings (LabCorp)
Dante Labs Inc.
Celemics, Inc.
Strand Life Sciences
Myriad Genetics, Inc.
QIAGEN GmbH
Tempus Labs
Others

Customization of Reports Available - https://www.marknteladvisors.com/query/request-customization/cancer-profiling-market.html

Key Report Highlights

Market Dimensions & Projections
Pricing Evaluation,
Recent Strategic Moves by Companies,
Primary Stakeholders,
Analysis of Import and Export Trends,
Competitive Landscape Assessment,
EmerCancer Profilingg Opportunities,
Market Trends and Indicators

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging Cancer Profilingg geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.